CureLab Oncology
Blood & Organ Banks · Massachusetts, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
177 Huntington Ave Ste 17, Boston, Massa...Website
www.curelaboncology.comRevenue
<$5 MillionIndustry
ZI Rank: 3
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
2
2
2
1
2
3
About CureLab Oncology
CureLab Oncology is a biotechnology company focused on developing innovative anti-cancer biologics, particularly their lead product, Elenagen, which is designed to enhance the anti-cancer effects of existing therapies and improve tumor microenvironments. The company is committed to creating revolutionary therapies aimed at prolonging the lives of oncology patients. CureLab Oncology has successfully completed Phase I/IIa clinical trials for Elenagen, demonstrating high safety and clinical benefits, and is now preparing for Phase II trials in the US. Their target clients include oncology patients and veterinary research sectors, as they also explore comparative medicine for dogs and cats.Explore more
CureLab Oncology Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is CureLab Oncology your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on CureLab Oncology recently announced quarterly report
Product Launch: Get notified when CureLab Oncology launches new products
CureLab Oncology, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once CureLab Oncology has new funding data
Check out if CureLab Oncology is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if CureLab Oncology has recently received funding, and reach out quickly before it becomes old news!
Click to see if CureLab Oncology had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at CureLab Oncology
Recommended Actions
Find VP level buyers at CureLab Oncology
Find 2 more new buyers
Compare Similar Companies to CureLab Oncology
Compare insights from companies similar to CureLab Oncology, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
CureLab Oncology is experiencing very low activity levels compared to other companies in the Healthcare Services sector.
What does this means?
CureLab Oncology is drawing exceptional interest within the Healthcare Services industry, suggesting notable developments or strong market momentum, learn more about CureLab Oncology.
CureLab Oncology financials insights
Gather financial insights about CureLab Oncology, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2023
Unspecified
$3M
CureLab Oncology Tech Stack
A closer look at the technologies used by CureLab Oncology
See more technologies
Most Recent Scoops
New Hire
Executive Move
Executive Moves, New Hire
Project
Research & Development, Intellectual Property, Legal Affairs, Medical Research
Funding
Funding
CureLab Oncology News & Media
CureLab Oncology Appoints Dr. Aubrey C. Galloway as Chief Medical Officer
Renowned cardiac surgeon to lead clinical development of innovative therapies targeting chronic inflammation across multiple diseases BOSTON, July 11, 2024 /PRNewswire/ -- CureLab Oncology, a clinical-stage biotech company, has appointed Dr. Aubrey C. Galloway as chief medical officer....CureLab Oncology publishes proof of concept demonstrating that its product can reduce the leading cause of age-related blindness
BOSTON, Oct. 2, 2018 /PRNewswire/ -- The journal Aging published the research conducted by CureLab Oncology, Inc. The paper demonstrates that a new biological agent developed by the company may prevent and alleviate age-related macular degeneration (AMD). AMD is a leading cause of age...
Read more news
Top Blood & Organ Banks Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding CureLab Oncology
Sign Up For FreeTo access detailed company insights
CureLab Oncology is a biotechnology company focused on developing innovative anti-cancer biologics, particularly their lead product, Elenagen, which is designed to enhance the anti-cancer effects of existing therapies and improve tumor microenvironments. The company is committed to creating revolutionary therapies aimed at prolonging the lives of o... Read More
